|
Market Cap (4-Jul) $37,640,252 (436th) |
Close (30-Jun) $0.310 |
Volume (30-Jun) 965,700 |
Shortsold (19-Jun) 470,735 (0.11%) (418th) |
|
52w High $0.130 |
52w Low $0.082 |
P/E 312.50 |
EPS -0.03 |
SPL released this announcement to the ASX on 5 May 2023, 17:04. The announcement is not marked as price sensitive, and is 7 page(s) in length and 26.53kb in size.
You can view all announcements from SPL and see how they appear on a price chart on the announcements page.
At the date of this announcement, SPL was 0.978% short sold according to ASIC data. It was ranked the 218th most shorted stock on the ASX. It remains ranked 418th as of the latest reported data (19 June 2025).
| Other Recent Announcements from SPL | |
|---|---|
| Clinical Trial Update | 27 June 2023, 9:57 |
| Life Sciences Investor Forum Presentation | 23 June 2023, 10:42 |
| Starpharma to present at Life Sciences Investor Forum | 22 June 2023, 12:48 |
| Application for quotation of securities - SPL | 5 May 2023, 17:04 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:31 |
| HER2-targeted DEP SN38 ADC outperforms in HER2 cancer model | 26 April 2023, 10:15 |
| AZD0466 active in small cell lung cancer patient models | 20 April 2023, 9:16 |
You must be logged in to post a reply.
Starpharma Holdings 